当前位置： SCI文献检索 > Journal of Infection in Developing Countries期刊下所有文献 > Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.

Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.

Abstract：

INTRODUCTION:Clostridium difficile is the leading cause of hospital-acquired diarrhoea. There is no defined protocol for treating severe Clostridium difficile infection (CDI) refractory to vancomycin or vancomycin and metronidazole combination therapy. The aim of this study was to evaluate the rate of clinical cure, time to resolution of diarrhoea and recurrence rate in patients with severe refractory CDI treated with oral teicoplanin. METHODOLOGY:A one-year prospective study was carried out in the Clinic for Infectious and Tropical Diseases, Clinical Center Serbia. Patients with severe and complicated CDI who failed to respond to oral vancomycin and intravenous metronidazole combination therapy were enrolled. They were given oral teicoplanin 100 mg bi-daily. Patients were followed for recurrence for eight weeks. RESULTS:Nine patients with a mean age of 70.8±9.4 years were analyzed. All patients had pseudomembranous colitis, and five had complicated disease. In four patients intracolonic delivery of vancomycin was also performed in addition to oral vancomycin and intravenous metronidazole prior to initiating teicoplanin, but without improvement. After teicoplanin initiation all patients achieved clinical cure. The mean time to resolution of diarrhoea after teicoplanin introduction was 6.3±4.5 days. There was no statistically significant difference in time to resolution of diarrhoea according to initial leucocyte count, age over 65 years, the presence of ileus, complicated disease and the use of concomitant antibiotic therapy (p = 0.652, 0,652, 0.374, 0.374, and 0,548, respectively). None of the patients experienced recurrence. CONCLUSIONS:Oral teicoplanin might be a potential treatment for severe and complicated refractory CDI, but further studies are required.

journal_name

J Infect Dev Ctries

journal_title

Journal of infection in developing countries

authors

Popovic N,Korac M,Nesic Z,Milosevic B,Urosevic A,Jevtovic D,Pelemis M,Delic D,Prostran M,Milosevic I

doi

10.3855/jidc.6335

subject

Has Abstract

pub_date

2015-10-29 00:00:00

pages

1062-7

issue

eissn

2036-6590

issn

1972-2680

journal_volume

pub_type

杂志文章

在线工具

Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.